Cart
sales@molnova.com
B-Raf IN 14
CAS No. 326918-98-3
B-Raf IN 14( —— )
Catalog No. M36431 CAS No. 326918-98-3
B-Raf IN 14 is a BRAF inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 174 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameB-Raf IN 14
-
NoteResearch use only, not for human use.
-
Brief DescriptionB-Raf IN 14 is a BRAF inhibitor.
-
DescriptionB-Raf IN 14 (Comp 25) is a BRAF inhibitor with IC50 value of 11.08 μM, which can be used in cancer-related research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetBradykinin Receptor
-
RecptorBradykinin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number326918-98-3
-
Formula Weight424.27
-
Molecular FormulaC15H14BrN5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1C2=C(N=C1SCC(N)=O)N(C)C(=O)NC2=O)C3=CC(Br)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cheng Luo, et al. ?Identification of BRAF inhibitors through in silico screening. J Med Chem. 2008 Oct 9;51(19):6121-6127.?
molnova catalog
related products
-
MK-0686
MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
-
Bradykinin (1-5)
Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).The bradykinin (BK) fragment (1-5) (RPPGF) is among the most stable of naturally occurring metabolites. Bradykinin (1-5) may be used as a marker for BK production in vivo.
-
Sar-[D-Phe8]-des-Arg...
Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo.
